HighTower Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.19M | Sell |
39,894
-5,876
| -13% | -$323K | ﹤0.01% | 1518 |
|
2025
Q1 | $3.24M | Buy |
45,770
+4,302
| +10% | +$304K | ﹤0.01% | 1254 |
|
2024
Q4 | $2.73M | Buy |
41,468
+10,930
| +36% | +$718K | ﹤0.01% | 1336 |
|
2024
Q3 | $2.15M | Buy |
30,538
+27,843
| +1,033% | +$1.96M | ﹤0.01% | 1477 |
|
2024
Q2 | $219K | Sell |
2,695
-4,454
| -62% | -$362K | ﹤0.01% | 2953 |
|
2024
Q1 | $626K | Sell |
7,149
-1,111
| -13% | -$97.3K | ﹤0.01% | 2111 |
|
2023
Q4 | $801K | Buy |
8,260
+563
| +7% | +$54.6K | ﹤0.01% | 1958 |
|
2023
Q3 | $681K | Buy |
7,697
+2,776
| +56% | +$246K | ﹤0.01% | 2007 |
|
2023
Q2 | $429K | Buy |
4,921
+25
| +0.5% | +$2.18K | ﹤0.01% | 2299 |
|
2023
Q1 | $478K | Sell |
4,896
-217
| -4% | -$21.2K | ﹤0.01% | 2126 |
|
2022
Q4 | $527K | Buy |
5,113
+315
| +7% | +$32.5K | ﹤0.01% | 2081 |
|
2022
Q3 | $406K | Sell |
4,798
-5,091
| -51% | -$431K | ﹤0.01% | 2140 |
|
2022
Q2 | $817K | Sell |
9,889
-576
| -6% | -$47.6K | ﹤0.01% | 1746 |
|
2022
Q1 | $808K | Sell |
10,465
-10,346
| -50% | -$799K | ﹤0.01% | 1871 |
|
2021
Q4 | $1.84M | Buy |
20,811
+6,361
| +44% | +$564K | ﹤0.01% | 1399 |
|
2021
Q3 | $1.12M | Buy |
14,450
+9,939
| +220% | +$767K | ﹤0.01% | 1585 |
|
2021
Q2 | $378K | Buy |
4,511
+319
| +8% | +$26.7K | ﹤0.01% | 2211 |
|
2021
Q1 | $319K | Buy |
4,192
+179
| +4% | +$13.6K | ﹤0.01% | 2247 |
|
2020
Q4 | $353K | Buy |
+4,013
| New | +$353K | ﹤0.01% | 1805 |
|
2020
Q3 | – | Sell |
-2,310
| Closed | -$281K | – | 2329 |
|
2020
Q2 | $281K | Sell |
2,310
-88
| -4% | -$10.7K | ﹤0.01% | 1766 |
|
2020
Q1 | $201K | Sell |
2,398
-91
| -4% | -$7.63K | ﹤0.01% | 1764 |
|
2019
Q4 | $208K | Buy |
+2,489
| New | +$208K | ﹤0.01% | 1938 |
|
2019
Q3 | – | Sell |
-5,051
| Closed | -$438K | – | 2271 |
|
2019
Q2 | $438K | Sell |
5,051
-970
| -16% | -$84.1K | ﹤0.01% | 1583 |
|
2019
Q1 | $535K | Sell |
6,021
-133
| -2% | -$11.8K | ﹤0.01% | 1423 |
|
2018
Q4 | $530K | Buy |
6,154
+1,057
| +21% | +$91K | ﹤0.01% | 1315 |
|
2018
Q3 | $493K | Buy |
5,097
+36
| +0.7% | +$3.48K | ﹤0.01% | 1464 |
|
2018
Q2 | $479K | Buy |
5,061
+1,801
| +55% | +$170K | ﹤0.01% | 1470 |
|
2018
Q1 | $264K | Sell |
3,260
-533
| -14% | -$43.2K | ﹤0.01% | 1732 |
|
2017
Q4 | $339K | Buy |
3,793
+1,206
| +47% | +$108K | ﹤0.01% | 1635 |
|
2017
Q3 | $244K | Sell |
2,587
-506
| -16% | -$47.7K | ﹤0.01% | 1788 |
|
2017
Q2 | $282K | Buy |
+3,093
| New | +$282K | ﹤0.01% | 1655 |
|
2016
Q2 | – | Sell |
-3,485
| Closed | -$285K | – | 1739 |
|
2016
Q1 | $285K | Sell |
3,485
-1,724
| -33% | -$141K | ﹤0.01% | 1562 |
|
2015
Q4 | $553K | Buy |
5,209
+2,559
| +97% | +$272K | 0.01% | 1260 |
|
2015
Q3 | $280K | Buy |
+2,650
| New | +$280K | ﹤0.01% | 1485 |
|
2015
Q1 | – | Sell |
-2,539
| Closed | -$230K | – | 1615 |
|
2014
Q4 | $230K | Buy |
+2,539
| New | +$230K | ﹤0.01% | 1342 |
|
2014
Q1 | – | Sell |
-3,234
| Closed | -$228K | – | 1479 |
|
2013
Q4 | $228K | Buy |
+3,234
| New | +$228K | ﹤0.01% | 1246 |
|